The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Friday 4 September 2015
Today, NHS England has announced a significant cut to the list of drugs that the Cancer Drugs Fund will fund. The drug bevacizumab (Avastin) was delisted for use in cervical, breast and colorectal cancers, but it is still available for use in ovarian cancer. Dr Simon Newman, Director of Research...
Monday 24 August 2015
Today, an article in the Daily Mail suggests taking beta blockers could extend the lives of women with ovarian cancer by up to four years.Beta blockers are most commonly prescribed for high blood pressure and heart problems. The study looked at health records of 1,400 women with ovarian cancer, and...
Thursday 6 August 2015
Today, the National Institute for Health and Clinical Excellence (NICE) has opened a second consulation on olaparib.  Olaparib has already been rejected by NICE for women with relapsed platinum sensitive BRCA-mutated ovarian cancer. The independent Appraisal Committee which developed the draft...
Tuesday 23 June 2015
New analysis by Target Ovarian Cancer warns that women are at risk of delayed diagnosis, lack of access to clinical trials and poorer survival outcomes, depending on their postcode. All women should have access to the best standards of care and treatment, wherever they live in the UK, says the...